Management guidelines for patients with thyroid nodules and differentiated thyroid cancer

被引：1553
作者：
Smith, BR
Cooper, DS
Doherty, GM
Haugen, BR
Kloos, RT
Lee, SL
Mandel, SJ
Mazzaferri, EL
McIver, B
Sherman, SI
Tuttle, RM
机构：
[1] Sinai Hosp Baltimore, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[4] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[5] Ohio State Univ, Sch Med & Publ Hlth, Columbus, OH 43210 USA
[6] Boston Univ, Med Ctr, Boston, MA USA
[7] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[8] Univ Florida, Coll Med, Gainesville, FL USA
[9] Mayo Clin, Rochester, MN USA
[10] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[11] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
THYROID | 2006年 / 16卷 / 02期
关键词：
D O I：
10.1089/thy.2006.16.109
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：109 / +
页数：31
相关论文
共 312 条
  • [61] Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy
    Dupuy, DE
    Monchik, JM
    Decrea, C
    Pisharodi, L
    [J]. SURGERY, 2001, 130 (06) : 971 - 977
  • [62] MEASUREMENT OF SERUM TSH AND THYROID-HORMONES IN MANAGEMENT OF TREATMENT OF THYROID-CARCINOMA WITH RADIOIODINE
    EDMONDS, CJ
    KERMODE, JC
    HAYES, S
    THOMPSON, BD
    [J]. BRITISH JOURNAL OF RADIOLOGY, 1977, 50 (599) : 799 - 807
  • [63] Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: Experience in 10,864 patients with nodular thyroid disorders
    Elisei, R
    Bottici, V
    Luchetti, F
    Di Coscio, G
    Romei, C
    Grasso, L
    Miccoli, P
    Iacconi, P
    Basolo, F
    Pinchera, A
    Pacini, F
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) : 163 - 168
  • [64] Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients
    Elisei, R
    Vivaldi, A
    Agate, L
    Molinaro, E
    Nencetti, C
    Grasso, L
    Pinchera, A
    Pacini, F
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) : 33 - 39
  • [65] Comparison of completion thyroidectomy and primary surgery for differentiated thyroid carcinoma
    Erdem, E
    Gülçelik, MA
    Kuru, B
    Alagöl, H
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (09): : 747 - 749
  • [66] Value of re-aspirations in benign nodular thyroid disease
    Erdogan, MF
    Kamel, N
    Aras, D
    Akdogan, A
    Baskal, N
    Erdogan, G
    [J]. THYROID, 1998, 8 (12) : 1087 - 1090
  • [67] Optimal treatment strategy in patients with papillary thyroid cancer: A decision analysis
    Esnaola, NF
    Cantor, SB
    Sherman, SI
    Lee, JE
    Evans, DB
    [J]. SURGERY, 2001, 130 (06) : 921 - 930
  • [68] Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma
    Eustatia-Rutten, CFA
    Romijn, JA
    Guijt, MJ
    Vielvoye, GJ
    van den Berg, R
    Corssmit, EPM
    Pereira, AM
    Smit, JWA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07) : 3184 - 3189
  • [69] Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis
    Eustatia-Rutten, CFA
    Smit, JWA
    Romijn, JA
    van der Kleij-Corssmit, EPM
    Pereira, AM
    Stokkel, MP
    Kievit, J
    [J]. CLINICAL ENDOCRINOLOGY, 2004, 61 (01) : 61 - 74
  • [70] Lack of impact of radioiodine therapy in Tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer
    Fatourechi, V
    Hay, ID
    Javedan, H
    Wiseman, GA
    Mullan, BP
    Gorman, CA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) : 1521 - 1526
234567891011